PAIN THERAPEUTICS, INC.

Inactive Instrument

Insiders Pain Therapeutics, Inc. Nasdaq

Equities

US69562K1007

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mar. 25	Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam	MT
Mar. 25	Cassava Sciences, Inc. Announces Completion of an Interim Safety Review of Oral Simufilam On-Going Phase 3 Trials	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cassava Sciences, Inc. Announces Board Appointments	Dec. 07	CI
Insider Buy: Cassava Sciences	23-08-24	MT
Insider Buy: Cassava Sciences	23-08-23	MT
Insider Buy: Cassava Sciences	23-03-08	MT
Cassava Sciences, Inc. Announces Executive Changes	22-12-20	CI
Cassava Sciences, Inc. Appoints Christopher Cook as Senior Vice President and General Counsel	22-10-27	CI
Insider Buy: Cassava Sciences	22-08-25	MT
Cassava Sciences, Inc. Appoints Richard J. Barry to Board of Directors, as Chair of the Nominating and Governance Committee and as Chair of the Audit Committee of the Board	21-06-14	CI
Cassava Sciences, Inc. Appoints James Kupiec as Chief Clinical Development Officer	21-01-04	CI
Cassava Sciences, Inc. Announces Lead Drug Candidate PTI-125 Is Assigned the Chemical Drug Name sumifilam by United States Adopted Names	20-08-24	CI
Cassava Sciences, Inc. Announces Resignation of Saira Ramasastry as a Member of the Board of Directors	20-06-19	CI
Pain Therapeutics, Inc. has Changed its Name to Cassava Sciences, Inc	19-03-27	CI
Pain Therapeutics, Inc. Appoints Eric Schoen as Chief Financial Officer, Effective on or Before November 7, 2018	18-10-11	CI
Pain Therapeutics, Inc. Announces Resignation of Peter S. Roddy as Vice President, Chief Financial Officer and Secretary	17-02-17	CI
Pain Therapeutics Announces Appointment of Michael Marsman as Senior Vice President, Regulatory Affairs	15-04-23	CI
Pain Therapeutics Inc. Announces to Eliminate the Position of Chief Scientific Officer, Effective October 31, 2014	14-10-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer